Related Experiment Videos

Gap junction synthesis and degradation as therapeutic targets

Eric C Beyer1, Viviana M Berthoud

  • 1Department of Pediatrics, University of Chicago, IL 60637-1470, USA. ebeyer@peds.bsd.uchicago.edu

Current Drug Targets
|November 27, 2002
PubMed
Summary

Modulating intercellular communication via gap junctions is possible by targeting connexin synthesis and degradation. Selective agents and genetic approaches offer promising therapeutic strategies with fewer side effects.

Related Concept Videos